These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 15201503)
1. Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney. Jeong HS; Park KK; Park KK; Kim SP; Choi IJ; Lee IK; Kim HC J Korean Med Sci; 2004 Jun; 19(3):374-83. PubMed ID: 15201503 [TBL] [Abstract][Full Text] [Related]
2. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo. Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Isaka Y; Tsujie M; Ando Y; Nakamura H; Kaneda Y; Imai E; Hori M Kidney Int; 2000 Nov; 58(5):1885-92. PubMed ID: 11044208 [TBL] [Abstract][Full Text] [Related]
4. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Han DC; Hoffman BB; Hong SW; Guo J; Ziyadeh FN Am J Physiol Renal Physiol; 2000 Apr; 278(4):F628-34. PubMed ID: 10751224 [TBL] [Abstract][Full Text] [Related]
5. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Lindschau C; Quass P; Menne J; Güler F; Fiebeler A; Leitges M; Luft FC; Haller H Hypertension; 2003 Sep; 42(3):335-41. PubMed ID: 12939231 [TBL] [Abstract][Full Text] [Related]
6. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996 [TBL] [Abstract][Full Text] [Related]
7. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855 [TBL] [Abstract][Full Text] [Related]
8. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism]. Zuo Y; Gu Y; Ma J; Lin S Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Hsieh TJ; Chen R; Zhang SL; Liu F; Brezniceanu ML; Whiteside CI; Fantus IG; Ingelfinger JR; Hamet P; Chan JS Kidney Int; 2006 Mar; 69(6):1005-15. PubMed ID: 16528250 [TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo. Marzo AL; Fitzpatrick DR; Robinson BW; Scott B Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy. Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017 [TBL] [Abstract][Full Text] [Related]
12. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Gilbert RE; Wilkinson-Berka JL; Johnson DW; Cox A; Soulis T; Wu LL; Kelly DJ; Jerums G; Pollock CA; Cooper ME Kidney Int; 1998 Oct; 54(4):1052-62. PubMed ID: 9767521 [TBL] [Abstract][Full Text] [Related]
14. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma. Kim SG; Song JY Oncol Rep; 2012 Aug; 28(2):539-44. PubMed ID: 22581233 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216 [TBL] [Abstract][Full Text] [Related]
17. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Chen A Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100 [TBL] [Abstract][Full Text] [Related]
18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment. Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Akagi Y; Isaka Y; Arai M; Kaneko T; Takenaka M; Moriyama T; Kaneda Y; Ando A; Orita Y; Kamada T; Ueda N; Imai E Kidney Int; 1996 Jul; 50(1):148-55. PubMed ID: 8807583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]